All-in-one pharmaceutical forecasting platform. FC365 simplifies complex forecasting via a centralised, shared cloud-based interface.| Evaluate
Pharma forecasting training, providing insight into sales, oncology and epi-based techniques, delivered by leading experts in the industry.| Evaluate
With Evaluate Data Feeds, integrate forecast, trial and key event data into your systems and workflows, saving time and accelerating strategic decision making| Evaluate
Evaluate's pharmaceutical consulting and analytics team provide expert solutions for your unique scientific, clinical, and commercial challenges, enhancing your strategy.| Evaluate
Biomedtracker provides a holistic view of the drug development landscape with real-time tracking of events, catalysts and deals.| Evaluate
Find out how Evaluate can help you - pharma & biotech, financial services, management consultancies, medtech & service providers to the pharma industry| Evaluate
Access all the crucial insights you need with Competitive Landscape Analysis, facilitating risk assessment, uncovering unmet needs, and gaining deeper insights into your growth drivers and product differentiators. Empower your SEO strategy with these optimized descriptions.| Evaluate
Company Profiling helps you discover, profile, and track the ideal companies aligned with your growth strategy.| Evaluate
Evaluate Commercial Opportunity Assessment integrates company financials, product attributes, consensus forecasts, and market insights to guide your strategic product placement effectively.| Evaluate
Unlock accurate, unbiased, and timely insights into pharmaceutical asset potential through our solutions. Forecast product-level risks, costs, and timelines to empower confident commercial decision-making.| Evaluate
Effective forecasting stands as a cornerstone for pharmaceutical and biotechnology enterprises, shaping strategies, mitigating risks, and propelling innovation forward. Elevate your decision-making with Evaluate Pharma, the premier destination for consensus forecasts trusted by pharmaceutical firms, investment banks, and consultancies alike.| Evaluate